Information design and architecture: combating drug-resistant infection

Dr. Rosemary Lim is a co-investigator on an exciting antimicrobial resisitance project funded by the Arts and Humanities Research Concil entitiled, ‘Information Design and Architecture in Persuaive Pharmacy space: combating AMR (IDAPPS)’.

Image result for Information design and architecture: combating drug-resistant infection

A design competition was recently held where groups of designers comprising of architects, information designers, pharmacists and others worked together to produce five great ideas for talking about drug-resistant infections. More information about the project and the winning designs can be found here https://amrpharmacy.org/five-ideas-for-talking-about-drug-resistant-infections/

Research collaboration

Dr. Rosemary Lim was recently awarded the certicate for new Research Collaborators with Berkshire Healthcare NHS Foundation Trust for 2017/18 in recognition of her study which explored medication use in people with Alzheimers.

The aim of the study, entitled ‘How do people with Alzheimer’s Disease and their family carers, view and manage medicine-taking?’, was to explore and explain medication non-adherence and the results have also been presented at Alzheimer’s Association International Conference 2017 in London.

Use of Technology to Support and Improve Wellbeing

 

Mona presenting her talk to staff

Mona Qasim, specialist mental health pharmacist, delivered a seminar to staff on Thursday 3rd May. The seminar focused on using techonolgy to support and improve well-being. In her talk, Mona introduced the Positive Mind Tool, a resource piloted by the university last year which showed positive results. Positive Online and mobile app use cognitive and behavioural psychology to help individuals track their psychological resilience and well-being.

The Positive App can be downloaded on Iphone by searching for the ‘Positive Health Strategies Ltd’ in the Apple store and on an Android device by searching for ‘Positive Group’ in the Android store. For more information, Mona can be contacted via her university email address, m.qassim@reading.ac.uk.

Dr. Donyai’s expert comments are in the news!

A study published this month in the BMJ reports an association between the use of certain anticholinergic drugs and the risk of dementia in the future. Dr Parastou Donyai, Associate Professor of Social and Cognitive Pharmacy, provided her expert comment on this study to the Science Media Centre and said,

“This paper ties in well with current advice for doctors to be careful when using drugs with anticholinergic effects in older people, those who are frail and others with numerous health conditions. The warning to not use anticholinergic drugs in Parkinson’s disease is also important. But the headline claim that some drugs, especially antidepressants, can cause dementia up to 20 years later should be looked at closely. This type of study imagines that patients actually take their drugs as they were prescribed for them. But we know from other research that people with long-term health conditions really only take their medication as prescribed around half of the time – the other half, people either take more or less of their medication or not at all. This issue of ‘non-adherence’ is common in people with heart conditions, stomach problems and mental health illnesses including depression and we want to be careful not to add to the problem. So my first comment is to remember that the paper really looked at the ‘prescribing’ of drugs rather than the ‘taking’ of these medications. This brings me to my second comment which is that anyone worried about taking their antidepressant as a result of this paper should speak to their doctor or pharmacist first and not suddenly stop their medication.”

Results from the study along with Dr. Parastou’s comments have also been reported in the BBC and The Guardian.

BBC: https://www.bbc.co.uk/news/health-43881209

The Guardian: https://www.theguardian.com/society/2018/apr/25/some-antidepressants-linked-to-dementia-risk

Link to study: https://doi.org/10.1136/bmj.k1315

Hamza Alhamad’s oral presentation at HSRPP 2018

Hamza presenting his work

Dr. Hamza recently completed his doctoral work investigating public attitudes towards the reuse of medication returned to community pharmacies. In his presentation at the HSRPP Conference held at the University of Newcastle this month, he reported the results of his cross-sectional study about the UK public’s intentions to reuse medications if this became a legislative possibility in the future. The conference abstract was published in the International Journal of Pharmacy Practice.

Alhamad H, Patel N, and Donyai P. Beliefs and intentions towards reusing medicines in the future: a large- scale, cross-sectional study of patients in the UK. Health Services Research and Pharmacy Practice Conference April 2018, University of Newcastle, UK. Int J Pharm Prac Vol 26 Issue S1.

https://doi.org/10.1111/ijpp.12440